How Much Did Rx Redefined Raise?
Funding & Key Investors

Rx Redefined, a company focused on transforming patient access to medical supplies, has secured $8M in total capital, with its most recent funding round bringing in $8M through a major strategic investment. This significant financial backing underscores the company's progress in its mission to empower patients in managing their care independently.

What is Rx Redefined?

Rx Redefined
ManufacturingMedical Devices & EquipmentHealthcare Software

Founded in 2018, Rx Redefined operates a platform designed to streamline the distribution of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) directly from physicians to patients. This innovative approach aims to enhance patient autonomy and improve the efficiency of medical supply management, positioning Rx Redefined as a key player in the evolving healthcare supply chain landscape. The company's focus on direct physician-to-patient distribution addresses critical needs in patient self-care and adherence to treatment plans.

How much funding has Rx Redefined raised?

Rx Redefined has raised a total of $8M across 1 funding round:

2023

Series A

$8M

Series A (2023): $8M with participation from Crosscut Ventures Management and Silverton Partners

Key Investors in Rx Redefined

Crosscut Ventures Management

Crosscut Ventures Management is an early-stage venture capital firm based in Los Angeles, focusing on innovative technology companies from Seed to Series A, particularly in energy transition, decarbonization, advanced manufacturing, and robotics.

Silverton Partners

Silverton Partners is a leading early-stage venture capital firm based in Austin, Texas, specializing in technology-driven companies with significant barriers to entry, known for its active investment in the Texas market.

What's next for Rx Redefined?

The recent major enterprise-level funding, characterized as a strategic investment, signals a pivotal growth phase for Rx Redefined. This capital infusion is expected to fuel further development of its distribution platform, expand its market reach, and potentially enhance its service offerings. The strategic nature of this financing suggests a focus on scaling operations and solidifying its market position, likely involving deeper integration with healthcare providers and a broader rollout of its patient-centric supply solutions. Rx Redefined is poised to leverage this investment to further its mission of enabling patients to manage their care with greater independence.

See full Rx Redefined company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturingAerospace & Defense
Building MaterialsManufacturingAutomotive Parts
Building MaterialsManufacturingConstruction ManagementConstruction
Building MaterialsManufacturingIndustrial Machinery & Equipment

Frequently Asked Questions Regarding Rx Redefined Financial Insights

What are the most recent funding rounds that Rx Redefined has completed, and what were the funding rounds?
Rx Redefined has recently completed 1 funding rounds: Series A on Jan 19, 2023.
What is the total amount of funding Rx Redefined has raised to date?
Rx Redefined has raised a total of $8M in funding to date.
How many funding rounds has Rx Redefined completed?
Rx Redefined has completed 1 funding rounds.
How much funding did Rx Redefined raise in its most recent funding round?
Rx Redefined raised $8M in its most recent funding round.
Who are the lead investors in Rx Redefined's latest funding round?
The lead investor in Rx Redefined's latest funding round was Crosscut Ventures Management. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Rx Redefined's history?
The largest funding round in Rx Redefined's history was $8M.
See more information about Rx Redefined